Alignment Healthcare, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)

About Alignment Healthcare, Inc.

Alignment Healthcare, Inc. (NASDAQ: ALHC) is a US healthcare company focused on managed care for seniors, with a core emphasis on Medicare Advantage. Founded in 2013, the company was built around a simple mission: improve care for older adults by combining clinical coordination, proprietary technology and a member-first service model. Its corporate headquarters are in Orange, California, United States. Alignment completed its IPO in March 2021, and its common stock trades on the NASDAQ market. The company’s business model is centered on integrated care delivery rather than a conventional broad-based insurance approach. Alignment designs and operates Medicare Advantage plans and works with physicians, hospitals and local provider partners to deliver coordinated care pathways, a 24/7 concierge-style care team and a proprietary technology platform called AVA®. Management positions AVA as a key differentiator: the platform leverages data and artificial intelligence to help identify clinical needs earlier, guide members to appropriate care, and support better quality outcomes while keeping medical costs under control. From a competitive standpoint, Alignment Healthcare stands out versus larger diversified health insurers because of its focus on senior consumers and its operational intensity in care management. In the highly competitive Medicare Advantage market, where reimbursement dynamics, utilization trends and regulatory oversight can materially affect profitability, Alignment aims to compete through tighter clinical execution, a more personalized member experience and data-driven decision-making. Recent operating momentum has been notable: in the first half of 2025, the company reported strong growth in membership and revenue and raised its full-year outlook after beating expectations in the quarter. Geographically, the business remains concentrated in the United States. It initially built its footprint in the West and has been expanding into additional markets over time, but its economic exposure is still tied primarily to the US Medicare Advantage environment. That means investors should think of Alignment as a domestic growth story with meaningful sensitivity to US healthcare policy, star ratings, medical cost trends and competitive plan design. Recent headlines have reinforced that growth narrative. In April 2025, Alignment strengthened leadership around AVA and member experience to scale its AI-enabled platform. In July 2025, it reported second-quarter results with substantial year-over-year increases in revenue and membership and raised guidance across key metrics. For investors, ALHC is best viewed as a specialist healthcare platform company with improving scale, a differentiated senior-care model and significant execution leverage, but also the usual sector risks tied to regulation, utilization and Medicare Advantage economics.